Rare diseases
Investigational molecules
Locations
Back to Latvia45 clinical trials in Liepaja, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
LatviaStudy Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy
LatviaLatviaStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
LatviaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
LatviaStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
LatviaStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
LatviaStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
LatviaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
LatviaStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
LatviaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
LatviaStudy on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis
LatviaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on treatments for psoriatic arthritis, ulcerative colitis, and systemic lupus erythematosus. Studies evaluate novel therapies including zasocitinib, eltrekibart, and upadacitinib for improved disease management.
Research aims to enhance treatment efficacy and patient outcomes in chronic inflammatory conditions.
Innovative studies targeting atherosclerotic cardiovascular disease and stroke prevention. Trials examine new medications like inclisiran and asundexian for managing cardiovascular risks and preventing major adverse events.
Focus on reducing cardiovascular events and improving patient outcomes in high-risk populations.
Research investigating treatments for bladder cancer and prostate cancer. Clinical trials evaluate innovative therapies including UGN-102 and novel combinations for various stages of cancer progression.
Studies aim to improve treatment options and outcomes for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
